LOW HBsAg LEVELS MAINTAINED FOLLOWING CESSATION OF THE GALNAC-siRNA, AB-729, IN CHRONIC HEPATITIS B SUBJECTS ON NUCLEOS(T)IDE ANALOGUE THERAPY

被引：0

作者：

Yuen, Man Fung ^{[1
]}

Berliba, Elina ^{[2
]}

Sukeepaisarnjaroen, Wattana ^{[3
]}

Tangkijvanich, Pisit ^{[4
]}

Leerapun, Apinya ^{[5
]}

Holmes, Jacinta A. ^{[6
]}

Gane, Edward J. ^{[7
]}

Jucov, Alina ^{[2
]}

Thi, Emily P. ^{[8
]}

Sofia, Michael J. ^{[8
]}

Sevinsky, Heather ^{[9
]}

Eley, Timothy ^{[9
]}

Medvedeva, Elina ^{[9
]}

Gray, Kevin ^{[9
]}

Antoniello, Deana ^{[9
]}

Picchio, Gaston R. ^{[9
]}

Sims, Karen ^{[9
]}

Strasser, Simone I. ^{[10
]}

机构：

[1] Univ Hong Kong, Hong Kong, Peoples R China

[2] Nicolae Testemitanu State Univ Med & Pharm Republ, Kishinev, Moldova

[3] Khon Kaen Univ, Srinagarind Hosp, Khon Kaen, Thailand

[4] Chulalongkorn Univ, Fac Med, Ctr Excellence Hepatitis & Liver Canc, Bangkok, Thailand

[5] Maharaj Nakorn Chiang Mai Hosp, Chiang Mai, Thailand

[6] St Vincents Hosp, Gastroenterol, Melbourne, Vic, Australia

[7] Univ Auckland, Auckland, New Zealand

[8] Arbutus Biopharma, Res Discovery, Warminster, PA USA

[9] Arbutus Biopharma, Clin Dev, Warminster, PA USA

[10] RPA, Liver Transplant, Sydney, NSW, Australia

来源：

HEPATOLOGY | 2021年 / 74卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

LP18

引用

页码：1402A / 1403A

页数：2

共 50 条

[31] Effect of Nucleos(t)ide Analogue Therapy on Risk of Intrahepatic Cholangiocarcinoma in Patients With Chronic Hepatitis B
Lee, Teng-Yu
Hsu, Yao-Chun
Yu, Shi-Hang
Lin, Jaw-Town
Wu, Ming-Shiang
Wu, Chun-Ying
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (06) : 947 - +
[32] Nucleos(t)ide analogue continuous therapy associated with reduced adverse outcomes of chronic hepatitis B
Su, Chien-Wei
Wu, Chun-Ying
Lin, Jaw-Town
Ho, Hsiu J.
Wu, Jaw-Ching
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2020, 83 (02) : 125 - 133
[33] Stopping Nucleos(t)ide Analogue Therapy in HBeAg-Negative Chronic Hepatitis B Reply
Liem, K. Seng
Gehring, Adam J.
Janssen, Harry L. A.
GASTROENTEROLOGY, 2020, 159 (03) : 1187 - 1188
[34] Hepatitis B Virus-Specific T Cells as a Biomarker for Discontinuation of Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B
Tian, Yongjun
Ou, Jing-hsiung James
HEPATOLOGY, 2019, 69 (03) : 1342 - 1344
[35] PREDICTION OF HBSAG LOSS USING HBSAG DECLINE AFTER LONG-TERM VIROLOGICAL RESPONSE TO NUCLEOS(T)IDE ANALOGUE THERAPY FOR CHRONIC HEPATITIS B
Zoutendijk, Roeand
Hansen, Bettina E.
van Vuuren, Anneke J.
Boucher, Charles A.
Janssen, Harry L.
HEPATOLOGY, 2010, 52 (04) : 509A - 509A
[36] Increased HBsAg Decline in Sustained Responders After Discontinuation of Long-term Nucleos(t)ide Analogue Therapy in Chronic Hepatitis B
Chi, Heng
Hansen, Bettina E.
Abu-Amara, Mahmoud
Yim, Colina
Arends, Pauline
Feld, Jordan J.
van der Eijk, Annemiek A.
de Knegt, Robert J.
Wong, David K.
Janssen, Harry L.
HEPATOLOGY, 2014, 60 : 1105A - 1105A
[37] CHANGES OF SERUM HBSAG LEVELS IN HBEAG-NEGATIVE CHRONIC HEPATITIS B PATIENTS UNDER LONG-TERM THERAPY WITH NUCLEOS(T)IDE ANALOGUE(S)
Papatheodordis, George V.
Goulis, Ioannis
Manolakopoulos, Spilios
Margariti, Ekaterini
Exarchos, Xenofon
Kokkonis, George
Papaioannou, Christos
Akriviasdis, Evangelos A.
Manesis, Emanuel K.
HEPATOLOGY, 2011, 54 : 1054A - 1054A
[38] The Role of Hepatitis B Surface Antigen in Nucleos(t)ide Analogue Cessation Among Asian Chronic Hepatitis B Patients: Friend or Foe?
Wang, Chia-Chi
Kao, Jia-Horng
HEPATOLOGY, 2019, 69 (04) : 1843 - 1843
[39] RETRACTED: Finite versus Indefinite Nucleos(t)ide Analogue Therapy of Patients with Chronic Hepatitis B Exhibiting Negative HBsAg Levels after Treatment (Retracted Article)
Sun, Haixia
Liu, Yinhui
Zhang, Yufeng
Jie, Yusheng
Wu, Yuankai
Li, Zhanyi
Wei, Xuxia
Li, Xiangyong
BIOMED RESEARCH INTERNATIONAL, 2022, 2022
[40] KINETICS OF QUANTITATIVE HBsAg DECLINE IN CHRONIC HEPATITIS B PATIENTS RECEIVING NUCLEOS( T) IDE ANTIVIRAL THERAPY
Hyun, Yong Gyu
Fung, Scott K.
HEPATOLOGY, 2023, 78 : S432 - S433

← 1 2 3 4 5 →